Molecular Templates is a clinical-stage biopharmaceutical company developing engineered toxin bodies (ETBs) for the treatment of cancers.
Location: United States, Texas, Austin
Total raised: $8.5M
Investors 8
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.10.2013 | Series C | $8.5M | - |
Mentions in press and media 7
| Date | Title | Description |
| 15.06.2026 | Hansa Biopharma appoints Adam Cutler as new Chief Financial Officer | Hansa Biopharma appoints Adam Cutler as new Chief Financial Officer Mon, Jun 15, 2026 07:00 CET Report this content Lund, Sweden, 15 June 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) announced today the appointment of Adam Cut... |
| 18.02.2021 | Molecular Templates, Inc. Announces Pricing of $75.9 Million Public Equity Offering | AUSTIN, Texas, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s proprietary engin... |
| 23.09.2020 | Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies | - Longitude Venture Partners IV will build on the Firm’s commitment to improve clinical outcomes, enhance patient quality of life, and drive efficiency in healthcare delivery - - In 2020 to date, Longitude portfolio companies announced 4 IP... |
| 23.09.2020 | Healthcare VC Firm Longitude Capital Closes $585M Fund | What You Should Know: – Healthcare venture capital firm Longitude Capital announces the close of its $585M Longitude Venture Partners IV, L.P. (“LVP4”) fund to invest in transformative healthcare companies. – LVP4 will invest opportunistica... |
| 21.07.2020 | Molecular Templates Raises $43 Million | AUSTIN, Texas, July 20, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s proprietary targeted biologic therapeutics, engi... |
| 21.07.2020 | MOLECULAR TEMPLATES, INC. Molecular Templates, Inc. Raises $43 Million in Gross Proceeds Through Its At-the-Market Facility | AUSTIN, Texas, July 20, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s ... |
| 08.10.2013 | Molecular Templates Raises $8.5M Series C Financing | Molecular Templates, Inc., a Georgetown, TX-based biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, raised an $8.5m Series C financing. The round was led by Excel Venture Management,... |